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Abstract 
The actin crosslinking domain (ACD) is an actin-specific toxin produced as a part of larger toxins 
by pathogenic Gram-negative bacteria Vibrio cholerae, Vibrio vulnificus, and Aeromonas 
hydrophila. When the toxin is delivered to the cell, ACD catalyzes the crosslinking of actin 
monomers into non-polymerizable actin oligomers of varying size. The current view is that the 
crosslinked oligomers have a passive role in damaging the cytoskeleton, i.e. that ACD activity 
disrupts the actin cytoskeleton due to a gradual accumulation of non-functional actin oligomers 
which leads to depletion of both the monomeric and filamentous actin pools. Due to the 
effectiveness of the toxin at low cellular concentrations, it is possible that the oligomers have a 
more active role in the disruption of the cytoskeleton.  
 Actin oligomers exhibit a unique combination of properties, different from G - and F-
actin, giving them the ability to interact with G-actin binding proteins while possessing tandem 
binding sites. We hypothesized that ACD-crosslinked oligomers should have a higher affinity for 
tandem actin-profilin binding proteins. Specifically, the ability of the formin homology 1 (FH1) 
domain of formins to bind profilin-actin complexes could be interrupted by these crosslinked 
actin oligomers. We tested this hypothesis by exploring the interactions of these actin oligomers 
with the mouse formin mDia1. The method used in order to study protein activity is pyrene-
labeled actin polymerization assay. We found that nanomolar concentrations of actin oligomers, 
when preincubated with profilin, inhibited mDia1-mediated polymerization in a concentration 
dependent manner. This project elucidates a novel, unexplored toxicity mechanism 
implemented by ACD to affect actin dynamics, leading ultimately to cell rounding and cell death. 
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Characterization of this inhibition highlights the striking efficiency of bacterial toxins and the 
ways in which they can hijack cellular machinery to accomplish their goals.  
1. Introduction 
Actin is a highly conserved structural protein found in nearly all eukaryotic cells. Actin is 
found in primarily two forms, filamentous (F-actin) and monomeric (G-actin), which exhibit 
distinct functional properties. Dynamic assembly of G-actin into F-actin filaments is important 
for numerous cellular functions including, but not limited to cell division, cell motility, and 
endo- and exocytosis (Schoenenberger et al., 2011). Monomeric actin has 4 subdomains, with 1 
and 3 being structurally similar and most likely arisen from gene duplication. Subdomains 2 and 
4 are also similar to each other and appear to be large insertions into subdomains 1 and 3 
(Figure 1) (Dominguez and Holmes, 2011). The subdomains are arranged to form two binding 
clefts. The cleft between subdomains 2 and 4 is responsible for nucleotide binding (ATP or ADP) 
and binding of a related cation (typically Mg2+) (Figure 1). The cleft between subdomains 1 and 
3 is lined by primarily hydrophobic residues and is involved in binding to several important 
regulators of actin dynamics – thymosin β4, cofilin, profilin, twinfilin, gelsolin, and other 
proteins (Dominguez and Holmes, 2011). G-actin can spontaneously polymerize into helical 
filaments (F-actin) under physiological conditions in vitro (Pollard and Cooper, 2009). 
Polymerization of filaments, along with formation of new filaments, is tightly regulated through 
the hydrolysis of ATP and the interaction with numerous actin binding proteins (ABP), including 
Arp2/3 complex proteins and formins, which are a focus of this study. Once a pre-existing 
filament is present, polymerization occurs very rapidly (Pollard and Cooper, 2009), unless 
filament ends are blocked (capped) with specific capping proteins. Actin filaments polymerize 
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faster at the barbed end (+), and at steady state conditions they will depolymerize at the 
pointed end (-) which allows for directional growth of filaments necessary for motility. In innate 
immunity, these actin functions are translated into chasing bacterial cells by macrophages and 
neutrophils, and eliminating pathogenic bacteria via secretion of humoral factors (e.g. 
antibodies, proteases, defense peptides, etc.) and by phagocytosis (Netea et al., 2012). The 
functional versatility of actin makes it an appealing target for bacterial toxins, allowing 
pathogens to undermine numerous vital functions of actin or hijack the actin cytoskeleton for 
their own benefits (Kudryashov et al., 2008a). 
Our studies focus on the actin crosslinking domain (ACD) - an actin-specific effector 
domain within the larger MARTX and VgrG1 toxins found in pathogenic Gram-negative bacteria 
Vibrio cholerae, Vibrio vulnificus, and Aeromonas hydrophila (Satchell, 2009). These bacteria are 
diarrheal pathogens which secrete enterotoxins to colonize the host intestines (Kudryashov et 
al., 2008a). Both toxins are known to induce rapid cell rounding in cell cultures due to the 
disassembly of filamentous actin (Satchell, 2009). MARTX toxins disrupt the cytoskeleton by 
two mechanisms: 1) the Rho-GTPase inhibitory domain (RID) shifts the cell’s actin equilibrium 
towards monomeric actin by adversely affecting actin cytoskeleton regulation by a family of 
small GTPases (Rho, Rac, Cdc42) (Kudryashov et al., 2008b). 2) ACD catalyzes the formation of 
an isopeptide bond between the K50 and E270 residues of two or more actin monomers, 
resulting in the formation of polymerization incompetent dimers, trimers, and higher order 
oligomers (Figure 2) (Cordero et al., 2006). As ACD crosslinks cellular actin monomers, this leads 
to the depolymerization of actin stress fibers causing cell rounding and eventually leading to 
cell death in severe cases . The activity of ACD is dependent on the normal cellular co-factors 
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ATP and Mg2+, but does not require the presence of other toxin domains or other host cell 
proteins (Cordero et al., 2006). The isopeptide bond formed during crosslinking exists between 
actin residues K50 and E270 which are located within the most flexible loops of actin 
(Kudryashov et al., 2008b). Both of these loops are unstructured and protrude from the body of 
the actin monomer. The crosslink brings together lysine and glutamine residues, whose alpha 
carbons are normally separated by a distance of 17 to 25 Å in actin filaments (Kudryashov et al., 
2008b). Therefore, the crosslinking disrupts the typical arrangement of actin protomers as they 
would exist in a filament which compromises their ability to participate in normal cellular 
functions. Because of this, the ACD-crosslinked actin oligomers do not polymerize.  
The current view of ACD pathogenesis is that these crosslinked actin oligomers have a 
passive role in disrupting the actin cytoskeleton due to a gradual accumulation of non-
functional actin oligomers and the depletion of both monomeric and filamentous actin pools  
(Figure 5) (Satchell, 2009). In contrast, we predict that the actual mechanisms by which ACD 
shuts down cellular functions of actin are more efficient, so that only a few copies of the toxin 
delivered to the cytoplasm of a host cell would suffice to adversely affect cellular actin 
dynamics. 
We propose that the actin oligomers actively affect normal interactions of actin with 
ABPs, and therefore the toxin can act at substantially lower doses and neutralize host immune 
cells faster than is currently recognized. We suggest that the structural difference between the 
ACD-crosslinked actin oligomers and both G- and F-actin translates into altered interactions of 
the actin oligomers with actin binding proteins. Actin oligomers exhibit the unique ability to 
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bind G-actin proteins, while at the same time possess multiple binding sites (a property of F-
actin). Particularly, we propose that due to a tandem organization, the ACD-crosslinked actin 
oligomers should have a substantially higher affinity to tandem actin binding proteins. To test 
this hypothesis, we focused on possible interactions between formins and crosslinked actin 
oligomers. 
The focus of this thesis project is on the impact of ACD crosslinked actin oligomers on 
formin-mediated actin polymerization, specifically the mouse formin mDia1. Formins are an 
important type of ABP involved for the formation of filopodia, polarized cell growth, and 
cytokinetic rings (Breitsprecher and Goode, 2013). Formins are a diverse class of proteins 
characterized by common formin homology domains but varying in functions and domain 
arrangement. The functional part of formin proteins consists of two domains known as formin 
homology domains I and II (FH1 and FH2), which are important for actin nucleation and 
elongation, respectively. FH2 is a highly structured domain composed of primarily alpha helices, 
which form a donut-shaped homodimer (Paul and Pollard, 2009). The lasso region at the N-
terminus of FH2 can bind to the post region at the C-terminus of the next subunit in order to 
stabilize the dimer. The FH2-FH2 dimer interacts with the barbed end of actin filaments and 
remains processively associated with the growing filament, efficiently blocking filament capping 
proteins (Figure 3) (Paul and Pollard, 2009). As new actin monomers are attached to the 
filaments, the FH2 dimer is able to move along with the growing filament end. Typically, actin 
filaments with FH2 bound at the end grow more slowly than free actin filaments, implying that 
FH2 works by a gating mechanism where it has open and closed conformations which either 
allow or prevent the addition of actin monomers, respectively (Paul and Pollard, 2009). It is 
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proposed that these changing conformations are responsible for the processive movement 
along the filament. The other important role of the FH2 domain is the stabilization of actin 
nuclei, a process known as nucleation. Nucleation of a new filament is the rate limiting step of 
actin polymerization as it requires 3 actin monomers to form the initial stable nucleus needed 
for the filament to grow. Once a nucleus of actin monomers or pre-existing filament is present, 
polymerization occurs very rapidly. The FH2 dimer assists in reducing the energetic cost of 
creating these nuclei and promotes their formation.   
While the FH2 dimer mediates nucleation and assists in attachment to the actin 
filament, the acceleration of filament elongation is performed by the FH1 domains located at 
the N-termini of the FH2 domains, resulting in two FH1 domains for each dimer. FH1 is believed 
to be an intrinsically unstructured domain containing tandem tracks of repeating proline 
residues (known as poly-proline rich regions). It is important to note that cellular G-actin exists 
in a complex with a sequestering protein, either profilin or thymosin β (Dominguez and Holmes, 
2011). Profilin binds to actin monomers at the barbed face (between subdomains I and III) 
preventing spontaneous nucleation of actin filaments (Bugyi and Carlier, 2010). The opposite 
side of profilin binds to poly-proline sequences, allowing profilin-actin complexes to interact 
with the poly-proline tracks of FH1 domains (Figure 4A).  
Because a majority of monomeric actin is in the profilin-actin complex, the interaction 
between profilin and formins is extremely relevant (Paul and Pollard, 2009). It is known that in 
the presence of low concentrations of profilin, FH1-FH2 domains of formins accelerate barbed 
end polymerization. The mechanism by which profilin-actin works together with formins to 
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accelerate polymerization is not explicitly known. However, it has been shown that poly-proline 
regions are able to bind profilin-actin complexes with varying affinities; the further the poly-
proline rich region is from the growing filament end, the higher the affinity (Courtemanche and 
Pollard, 2012). The accepted mechanism suggests that formins accelerate the rate of 
polymerization by increasing the local concentration of actin near the barbed end (Figure 4A) 
(Paul and Pollard, 2009). This allows for actin monomers to be quickly incorporated into the 
filament as they are brought to the barbed end with the aid of the flexible FH1 arms.  
The reason we chose to focus on formins in the context of the ACD toxin is because they 
possess the FH1 domain which has tandem actin-profilin binding sites. Specifically, we 
hypothesized that this tandem arrangement will allow for significantly stronger interactions 
between actin oligomers and FH1 than lone profilin-actin complexes. The regions connected by 
the covalent bond in actin oligomers are located away from the profilin binding site in the 
hydrophobic cleft of actin and profilin does not inhibit the crosslinking reaction (Figure 5). This 
allows for the actin oligomers to bind profilin and therefore interact with the poly-proline 
regions in FH1 domains of formins. If properly spaced, the complexes of profilin and the 
crosslinked oligomers would bind to FH1 domains of formins with great affinity due to the 
avidity of multiple binding sites allowing for stronger interactions. Ultimately, the goal of this 
project is to test the formulated hypothesis and study the effects of ACD-crosslinked actin 
oligomers on mDia1-mediated polymerization in vitro using bulk pyrene-actin polymerization 
assay. If interactions are occurring between the profilin-bound actin oligomers and mDia1, the 
polymerization-accelerating function of mDia1 should be altered.  
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2. Results and Discussion 
2.1 Optimization of mDia1 purification and storage conditions 
Preparation of the C-terminal fragment of mDia1 (MBP-FH1-FH2-6xHis-tag) was started 
by transformation of pET21A vector into E. Coli and overexpression; this vector was received as 
a gift from Dr. David Kovar (University of Chicago). The protein contains a maltose binding 
protein (MBP) domain and a 6xHis-tag allowing for either amylase resin or immobilized metal 
affinity chromatography (IMAC) purification, respectively (Figure 6).  We were able to increase 
protein yield by making improvements to the bacterial overexpression protocol. Sequence 
analysis, using a ProtParam program (ExPASy), revealed that mDia1 contains 130 total prolines, 
located primarily within the FH1 domain poly-proline tracks (Gasteiger et al.). Therefore, we 
supplemented our growth medium with 0.5 mM of free L-proline during protein expression 
(Figure 7). We speculate that the addition of free proline reduces the stress on the cells to 
produce proline for protein synthesis and ultimately results in a better yield of mDia1. 
Conventional expression conditions followed by initial IMAC purifications yielded approximately 
0.84 mg protein/L of media, while supplementation with free L-proline resulted in a near four 
fold increase (3.3 mg protein/L of media) in yield (Figure 7).  
It has been previously reported that mDia1 cannot be frozen following purification 
without a significant loss of activity (Moseley et al., 2006). Therefore, we explored methods 
that would allow for long term storage of mDia1. We explored the storage conditions by 
supplementing mDia1 with 50% glycerol or 50% ethylene glycol and freezing at -20 °C, or 
leaving mDia1 at 4 °C. After 2 weeks, all samples were tested for their efficiency of actin 
nucleation and elongation (Figure 8). The highest retained activity was from the sample stored 
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at -20 °C in 50% glycerol; this condition was used routinely to preserve to purified protein for 
subsequent experiments.  
2.2 Profilin purification and isoform selection 
As a class of proteins, profilins are specialized in regulating actin polymerization, but 
also have the ability to interact with repeating sequences of proline residues, known as poly-
proline tracks. This allows for various isoforms of profilin to be purified using highly specific 
type of column chromatography. Free poly-L-proline can be attached to Sepharose resin in 
order to make a chromatography column which will specifically bind to profilins. This allows for 
the binding of any profilin isoform on this column under native conditions and elution with 
increasing concentrations of denaturants. After purification using the poly-L-proline column, 
profilin can be further cleaned up with fast protein liquid chromatography (FPLC) to remove 
high molecular weight contaminants. Refolding of human profilin I was carried out by repetitive 
dialysis changes into storage buffer which lacks the denaturant. It was also important to 
determine which species-specific form of profilin would be optimal to use with mDia1. We 
purified and tested profilin from Mus musculus, Saccharomyces pombe, and Homo sapiens 
using the poly-L-proline column, and tested the effect on mDia1-mediated polymerization. Our 
results showed that mDia1 functioned best with human profilin (hPro1), so this isoform was 
selected for our experiments.  
2.3 Actin-oligomer formation by ACD 
The reproducible formation of actin oligomers by ACD was a critical step for generating 
consistent results. Due to ACD being able to crosslink any free actin monomers, active ACD 
must either be removed or inactivated after the formation of actin oligomers. Initially a 6xHis-
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tagged ACD from Vibrio cholera (ACDVc) was used, removal of which was attempted by mixing 
the reaction with TALON cobalt resin. This method resulted in some loss of actin oligomers 
through non-specific binding to the resin. Moreover, it was observed that this method did not 
completely remove ACDVc from our reactions. Actin crosslinking occurring in our bulk pyrene-
actin polymerization assays was evident on an SDS-PAGE gel confirming the presence of active 
ACD (Figure 9). The concentrations of oligomers used in this polymerization assay were in the 
nanomolar range, therefore they cannot be visualized by SDS-PAGE, meaning new additional 
oligomers were being formed by active toxin. This control shows that even residual amounts of 
ACD were able to cause significant crosslinking of pyrene-labeled actin, thus producing artificial 
results. To resolve this issue, we used an ortholog from Aeromonas hydrophila (ACDAh), a 
psycroptrophic, gram negative bacteria. Our lab has shown that ACDAh,, when heated to 42 °C, is 
unfolded and deactivated. Using ACDAh removed the need for using IMAC purification, since 
thermal treatment ultimately eliminated any ACD activity. Following heat inactivation of ACDAh, 
stability and lifetime of actin oligomers on ice was improved by supplementation with 1 mM of 
ATP. Inactivation by heat showed to be efficient and reliable, allowing us to successfully 
synthesize fully functional actin oligomers that were free of active ACDAh. 
2.4 Effects of actin oligomers on mDia1-mediated polymerization, observed by bulk pyrene-
actin polymerization assay 
Pyrene-actin bulk polymerization assay is an effective method of observing bulk actin 
polymerization rates in vitro. It allows for a measurement of actin polymerization rates by 
observing the increase in fluorescent signal emitted by pyrene-actin as it is incorporated into 
filaments. It has been shown that the fluorescent signal is independent of filament length 
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distribution, and that pyrene-actin and regular actin exhibit the same time course of 
polymerization, elongation rate constants, intrinsic viscosity, and critical concentration (Cooper 
et al., 1983). This allows for an overall view of how quickly monomeric actin is being 
incorporated into filaments, with the rate being proportional to the increase in fluorescent 
signal. This assay is highly sensitive and is optimal for studying actin polymerization in vitro, 
because it does not interfere with regular actin filament dynamics.  
Under normal cellular conditions, mDia1 greatly increases actin filament polymerization 
rates in the presence of profilin. We hypothesized that actin oligomers, which can also bind 
profilin, may be able to also occupy these tandem sites and inhibit mDia1 mediated 
polymerization. As controls, we first compared the rates of actin polymerization and mDia1 
accelerated polymerization in the presence and absence of nanomolar concentrations of actin 
oligomers, with no profilin present. Because the tandem-binding sites of mDia1 possess poly-
proline tracks, the binding of actin-profilin complexes depends on the ability of profilin to bind 
actin and then also bind to the poly-proline regions. In this situation, the actin oligomers should 
have no way of binding to or interfering with mDia1. The addition of actin oligomers to either 
system did not affect actin polymerization rates, meaning our controls verified that the 
interaction requires profilin, and that actin oligomers on their own do not affect the dynamics 
of this system (Figure 10).  
Next, in order to test our hypothesis, we introduced human profilin into the system and 
observed how varying concentrations of actin oligomers affected polymerization. While holding 
actin and profilin concentrations at 2.5 uM and 5 uM, respectively, and mDia1 in a low 
nanomolar range (between 1 and 10 nM), we varied the concentrations of actin oligomers from 
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200 pM to 10 nM. At concentrations of actin oligomers that exceed the amount of mDia1 
present, we found that polymerization was completely inhibited. Using varying concentrations 
of actin oligomers below the concentration of mDia1 showed a dose-dependent inhibition 
(Figure 11). In the experiment depicted in Figure 11, a concentration of 5 nM mDia1 was used, 
along with concentrations of oligomers ranging from 1-10 nM. Next, we used our titration data 
to make an estimate of the binding affinity between actin oligomers and the FH1 domain. This 
value was determined by fitting the inhibition seen by actin oligomers on elongation rates to an 
isothermal binding curve (Figure 12). Data for curve was collected by observing the time it takes 
for the reaction to reach half the value of the polymerization plateau. At this halfway point, the 
slope was measured to give a value for the rate of the reaction at those conditions. By plotting 
a relative rate of elongation versus the concentration of actin oligomers, we found an apparent 
KD in the sub-nanomolar range (0.089 nM, Figure 12) of the actin oligomers for the mDia1 FH1 
domains. This value for KD is not exact because the experiment involves using a mixed 
population of actin oligomers, varying in size. Varying sized actin oligomers will have different 
affinities, meaning our mixed sample will give us an overall average of all different actin 
oligomers, making it an apparent estimate for the whole population. This strong binding affinity 
confirms our hypothesis that the tandem binding sites of actin oligomers allow for significantly 
stronger interactions with FH1 than lone profilin-actin complexes.  
Because the inhibitory effect of the actin oligomers on mDia1 was not observed in the 
absence of profilin, the inhibition is profilin-dependent. The only way that profilin interacts with 
mDia1 is through the tandem poly-proline regions of the FH1 domain, implying that the profilin-
bound actin oligomers bind to these regions via profilin interactions. Our data show that the 
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actin oligomers actually have an even stronger affinity for these sites than profilin-actin 
complexes because the actin oligomers can bind to multiple sites at the same time. Once 
bound, the actin oligomers are able to block the FH1 domain and prevent it from bringing in 
new actin-profilin complexes for filament elongation, ultimately shutting down the elongation 
activity of mDia1.   
Our data indicate that the actin oligomers have functionality and effects on other 
cellular proteins, not previously known in the field of ACD-containing toxins. This means that 
the damage caused to cells by ACD is more complex than just the depletion of free actin and a 
shutdown of cells by disassembly of the actin cytoskeleton. Bacterial toxins have evolved to 
function at maximum efficiency, using the crosslinked actin oligomers produced by the toxin as 
tools to interfere with functions of other cellular proteins. The inhibitory effects shown here 
demonstrate how highly efficient bacterial pathogens can be and how they are able to greatly 
affect vital cellular functions with only a small amount of toxin and/or crosslinked actin.  
The significance of this project is multifaceted. First, the project provides a novel insight 
into the mechanism of the host immune system subversion by pathogenic bacteria. Second, 
studying the ACD-containing MARTX and VgrG1 toxins, produced by Vibrio cholera and other 
human pathogens, provides an understanding of their pathogenic pathways which can help in 
facilitating their efficient elimination. Finally, formins have not previously been identified as 
targets of bacterial toxins. This highlights the fact that our understanding of how these toxins 
carry out their function is still not fully complete and their mechanisms are more complicated 
than previously believed. The understanding of the detailed role of the ACD-crosslinked actin 
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oligomers should allow us to create tools to ultimately study and control formin mediated 
processes. 
3. Future Directions 
3.1 Cloning and expression of FH1 for fluorescence anisotropy 
To evaluate the affinity of profilin-bound actin oligomers for the poly-proline tracks, we 
attempted to clone and purify only the FH1 domain of mDia1. Initially, we used polymerase 
chain reaction (PCR), with primers designed to amplify the sequence coding only the FH1 
domain of mDia1. The PCR product was cloned into pCold-TEV using the In-Fusion cloning 
system (Clontech, Mountain View, CA). In-Fusion uses the vacinnia virus DNA polymerase 
(VVpol) which takes advantage of complementary strands between the vector and the PCR 
product to perform single-strand annealing that fuses the PCR product with the vector (Irwin et 
al., 2012). However, we were not able to successively purify FH1 following overexpression. This 
was confirmed through MALDI, which showed that the molecular weights of the pure species 
did not match with the predicted molecular weight of the FH1 domain. FH1 domains are highly 
disordered regions and may be easily degraded by proteases or be insoluble upon expression. 
To overcome these issues, we recently have attempted to increase the stability/solubility of 
FH1 by fusion with MBP at the N-terminus of FH1 (MBP-FH1) Once expressed and purified, FH1 
can be labeled with the amine-reactive fluorescent probe Atto610 to determine the binding 
affinities of actin oligomers to mDia1 FH1 domains using fluorescence anisotropy assays (Park 
and Raines). FA quantifies changes in polarization (which is a function of size/tumbling rate) of a 
fluorescently-labeled protein due to its interaction with other, preferably larger, molecules. 
Therefore, the affinity of FH1 domains for actin oligomers of different sizes in the presence of 
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profilin will be measured by detecting changes in anisotropy of the Atto610 probe bound to the 
FH1 domain. Understanding the strength of this binding will give significant insight into the 
strength of this interaction and inhibitory effect. 
3.2 Cloning and expression of FH2-FH1FH2 heterodimer 
To further study the inhibitory effect of actin oligomers on mDia1, and differentiate 
whether the effect occurs by binding to a single FH1 arm, cross-two arm, or a mixed binding of 
actin oligomers, we produced a “single-armed” mDia1, consisting of two FH1 domains and one 
FH1 domain (Figure 4C). Due to the high affinity of FH2 domains for each other, we expect that 
co-expression of a FH1-FH2 and a FH2 domain, with different tags, will allow for isolation of the 
heterodimeric protein (Courtemanche and Pollard, 2012). For the coexpression, the pETDuet-1 
vector was chosen because it possesses two separate multiple cloning sites (MCS) with both 
under the control of the T7 promoter, allowing for the co-expression of two proteins. To allow 
for the purification of the heterodimer, two different affinity tags would need to be present in 
the sequence. First, we inserted MBP-FH1-FH2 into MCS1, followed by insertion of FH2-6xHis 
into MCS2. This order of insertions was vital because the restriction enzymes used for the first 
cloning event (NcoI and HindIII) would also have digested part of the FH2 sequence had the 
order been reversed. The set of restriction enzymes used for the second cloning event (NdeI 
and XhoI) could be safely used as they did not cut outside of MCS2. Following sequencing 
verification that both inserts where correct, the resulting plasmid was transformed into 
BL21(DE3)-pLysS expression cells.  
We optimized the expression of the heterodimer by testing it under varying conditions. 
Initially, ten different colonies were screened on a small scale using varying temperatures (16, 
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25, and 37 °C), concentrations of ITPG (0.5, 1, and 2 mM), and the length of expression (2.5, 4, 
8, and 16 hours). The best expression was found from expression at 37 °C overnight induced 
with 1 mM IPTG (Figure 13). Using this clone, expression was carried out in 2 L of growth 
medium under the identified optimal conditions. Isolation of the heterodimer required a 
tandem purification set up that would allow us to separate it from two homodimers. First, IMAC 
purification would allow for the removal of the MBP-FH1-HF2 homodimer, because it does not 
contain a 6xHis tag. Following elution with imidazole from IMAC column, the eluted fractions 
containing proteins need to be buffer exchanged by dialysis into amylase-column binding buffer 
prior to MBP-purification. This will result in the separation of the 6x His-tagged FH2-FH2 
homodimer (in the flow through) and the heterodimer (bound to the resin). Following elution 
with 10 mM maltose, the heterodimer will be dialyzed into formin storage buffer A (see 
methods). Once successfully expressed and purified, this heterodimer can be used in the same 
bulk pyrene polymerization assays to further study the mechanism of observed actin-oligomer 
inhibition. This protein is currently in the process of being tested but no results are available at 
the time of this document. 
4. Materials and Methods 
 This chapter outlines and describes the protocols used to prepare and carry out the 
experiments described previously. Preparation of acetone powder of rabbit muscle, monomeric 
actin preparation, and cloning for FH1 and FH2-FH1FH2 heterodimer was done in collaboration 
with graduate student David Heisler. Preparation of pyrene labeled actin was done by David 
Heisler. Actin was prepared from rabbit muscle acetone powder (Pardee and Spudich, 1982). 
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After extraction from the acetone powder, fresh G-actin was prepared by dialysis overnight 
against a G-buffer: 2 mM Tris-HCl pH 8, 0.2 mM CaCl2, and 0.2 mM ATP. 
4.1 MBP-FH1-FH2-6xHis purification 
  To prepare MBP-FH1-FH2-6xHis (C-terminus of mDia1), we transformed pET21A vector 
encoding the sequence of interest into BL21 Codon Plus E. coli under ampicillin and 
chloramphenicol resistance. Cell cultures were grown up to OD600=1.2 in MMI media (1.25% 
tryptone, 2.5% Sigma yeast extract, 125 mM NaCl, 0.4% glycerol, 50 mM Tris pH=8.2) before 
induction. mDia1 expression was initiated with addition of 1 mM IPTG and 0.5 mM L-proline 
and was continued for 6 hours at 25 ˚C. Cells were pelleted at 3000 xg for 20 min at 4 C. Pellets 
were then resuspended in buffer A (50 mM NaH2PO4, 500 mM NaCl, 10% glycerol, 10 mM 
imidazole, pH=8.0) supplemented with protease inhibitors (2 ug/mL Leupeptin/Pepstatin, 2 
ug/mL Trypsin inhibitor) and then freeze-thawed using liquid nitrogen three times to activate 
lysozyme to break down cell walls. The cell lysate was sonicated twice under the following 
conditions: 60% amplitude, 6 second pulse, 1 second off, 2 minutes sonication. Next, the lysate 
was clarified by centrifugation at 20,000 rpm for 20 min at 4 ˚C. The supernatant was then 
filtered through a Whatman filter and supplemented with 0.1 mM PMSF. This lysate was 
nutated with Talon cobalt resin beads (Clontech) for 1 hour and then loaded onto a column. 
The resin was washed with 50 mL of buffer A, then washed with 15 mL of buffer A 
supplemented with 20 mM imidazole, and finally the protein was eluted in 1.5 mL fractions by 
using buffer A supplemented with 250 mM imidazole. The content of each fraction was 
analyzed by SDS-PAGE and samples with purified protein were pooled, concentrated, and 
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dialyzed into storage buffer for later use (20 mM Tris pH=8.5, 50 mM NaCl, 5% glycerol, 0.01% 
NaN3). 
4.2 ACD purification 
To prepare His-LFN-ACDVc, we transformed pCold vector encoding the sequence of 
interest into BL21 DE3 P-Lys E. coli under ampicillin and chloramphenicol resistance. Cell 
cultures were grown up to OD600=1.2 in MMI media before induction. His-LFN-ACDVc expression 
was initiated with addition of 1 mM IPTG and was continued for 16 hours at 15 ˚C. After 
expression, cells were pelleted at 3000 xg for 20 min at 4 ˚C. Pellets were then resuspended in 
buffer B (20 mM Tris, 500 mM NaCl, 2 mM MgCl2, 10 mM imidazole, 0.5 mM PMSF, pH=8.0) 
supplemented with protease inhibitors (2 ug/mL Leupeptin/Pepstatin, 2 ug/mL Trypsin 
inhibitor) and then freeze-thawed using liquid nitrogen three times to activate lysozyme to 
break down cell walls. The cell lysate was sonicated twice under the following conditions: 60% 
amplitude, 6 second pulse, 1 second off, 2 minutes sonication. Next, the lysate was clarified by 
centrifugation at 20,000 rpm for 20 min at 4 ˚C. The supernatant was then filtered through a 
Whatman filter and supplemented with 0.1 mM PMSF. This lysate was nutated with Talon 
cobalt resin beads (Clontech) for 1 hour and then loaded onto a column. The resin was washed 
with 80 mL of buffer B, then washed with 15 mL of buffer B supplemented with 20 mM 
imidazole, then washed with 15 mL of buffer B supplemented with 50 mM imidazole, and finally 
the protein was eluted in 1.5 mL fractions using buffer B supplemented with 250 mM imidazole. 
The content of each fraction was analyzed by SDS-PAGE and samples with minimal 
contamination were pooled, concentrated, and dialyzed for later usage (20 mM Tris pH=8.5, 50 
mM NaCl, 5% glycerol, 0.01% NaN3). 
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4.3 Human profilin purification 
To prepare hPro1, we transformed pMW vector encoding the sequence of interest into 
BL21 DE3 P-Lys E. coli carrying ampicillin and chloramphenicol resistance. Cell cultures were 
grown up to OD600=1.2 in MMI media before induction. hPro1 expression was initiated with 
addition of 1 mM IPTG and was continued for 4 hours at 37 ˚C. After expression, cells were 
pelleted at 3000 xg for 20 min at 4 ˚C. Pellets were then resuspended in buffer C (10 mM Tris, 
150 mM NaCl, 1 mM EDTA, 1 mM DTT, pH=8.0) supplemented with protease inhibitors (2 ug/mL 
Leupeptin/Pepstatin, 2 ug/mL Trypsin inhibitor) and then freeze-thawed using liquid nitrogen 
three times to activate lysozyme to break down cell walls. The cell lysate was sonicated twice 
under the following conditions: 60% amplitude, 6 second pulse, 1 second off, 2 minutes 
sonication. Next, the lysate was clarified by centrifugation at 20,000 rpm for 20 min at 4 ˚C. The 
supernatant was then filtered through a Whatman filter and supplemented with 0.1 mM PMSF. 
This lysate was nutated with poly-L-proline resin for 1 hour and then loaded onto a column. The 
resin was washed with 100 mL of buffer C, then washed with 50 mL of buffer C supplemented 
with 1 M Urea, and finally the protein was eluted in 1.5 mL fractions using buffer C 
supplemented with 3 M Urea. The content of each fraction was analyzed by SDS-PAGE and 
samples with purified protein were pooled, concentrated, and dialyzed for later usage (2 mM 
Tris pH=8.0, 0.2 mM EGTA, 1 mM DTT, 0.01% NaN3).  
4.4 Actin crosslinking by ACD 
 The ACD crosslinking reaction was carried out by crosslinking 20 uM of skeletal actin 
with 10 nM of ACDAh in oligomer reaction buffer (10 mM Tris pH=8.0, 0.1 mM PMSF, 200 uM 
ATP). Actin was diluted from an initial 100 uM stock containing 0.2 mM Ca2+. All components 
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except MgCl2 were combined and equilibrated to the same temperature by storage on ice, and 
then the reaction was initiated with addition of 1 mM MgCl2. After initiation, the reaction was 
ran at 10 C for 15 minutes, then heated to 42 ˚C for 10 minutes and supplemented with 
additional 2 mM MgCl2. Additional MgCl2 was added to polymerize any actin that had not been 
crosslinked once ACD was inactivated by heat. Next, this reaction was chilled on ice for 5 
minutes and then held at room temperature for 15 minutes before centrifuging at 90,000 rpm 
for 30 minutes at 4 ˚C to separate actin oligomers from actin filaments. The resulting 
supernatant was supplemented with 1 mM ATP and kept on ice for storage and use in 
experiments.  
 
 
4.5 Bulk pyrene-actin polymerization assays 
Bulk pyrene-actin polymerization assays were set up by pre-incubating all of our 
proteins of interest before initiation of the polymerization reaction with MgCl2. Formin reaction 
buffer (10 mM MOPS pH=7.0, 0.2 mM ATP, 0.5 mM DTT) was combined with 2.5 uM pyrene 
actin (5% labeled), and depending on the specific sample, also combined with hProf1 (5 uM), 
mDia1 (1-10 nM), or actin oligomers (0.2-10 nM). Samples were loaded into a 384 well plate 
and fluorescence was measured by excitation at 366 nM and reading emission at 407 nM. Next, 
calcium ions were chelated using switch buffer (10 mM MOPS pH=7.0, 0.2 mM ATP, 0.5 mM 
DTT, 0.3 mM EGTA, 0.1 mM MgCl2) and fluorescence was measured for another 2 minutes. The 
reaction was initiated with initiation buffer (10 mM MOPS pH=7.0, 0.2 mM ATP, 0.5 mM DTT, 1 
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mM MgCl2) and fluorescence was measured until polymerization was complete. Changes in 
fluorescence were measured for 4 hours with time points taken every 30 seconds.  
4.6 PCR and cloning of recombinant proteins 
 PCR for making recombinant MBP-FH1 was run in 1x Phusion GC buffer (New England 
Biolabs), combined with 200 uM dNTPs, 500 nM of both forward and reverse primers, 10 ng of 
MBP-FH1-FH2-6xHis plasmid (KV373) as a template, and 6% ethylene glycol. 1 unit of Phusion 
polymerase (New England Biolabs) was added to initiate the PCR reaction. Initial denaturation 
was ran for 30 seconds at 98 C. The PCR was then run for 30 cycles with a denaturation step (10 
seconds, 98 ˚C), an annealing step (30 seconds, 55-72 ˚C), and an extension step (30 seconds, 72 
˚C). The PCR product was confirmed to be the correct size by agarose gel electrophoresis and 
then purified from the gel. This PCR product was transformed into pColdTEV, a modified 
expression vector containing a protease cleavage site, using the Clontech InFusion kit. The 
InFusion reaction was run by combining digested pColdTEV with MBP-FH1 PCR product and the 
InFusion polymerase and the reaction was performed at 50 ˚C for 15 minutes. The product of 
the InFusion reaction was transformed into DH5α competent cells, purified and confirmed by 
sequencing.  
PCR and cloning reactions for the heterodimer constructs were performed using the 
same reagents with appropriate plasmids and primers for heterodimer sequences. Two PCR 
products were made: one containing the sequence of FH2-6xHis, and one containing the 
sequence of MBP-FH1-FH2. First, we inserted MBP-FH1-FH2 into the first multiple cloning site 
of pETDuet by InFusion. Next, FH2-6xHis was inserted into the second multiple cloning site by 
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InFusion. InFusion reaction conditions in both cloning events were 50 ˚C for 15 minutes. In each 
InFusion reaction, the cut plasmid was prepared by digesting pETDuet with NcoIII and HindIII 
for multiple cloning site 1 and Nde1 and Xho1 for multiple cloning site 2. Following sequencing 
verification, the resulting plasmid will be transformed into BL21(DE3)-pLysS expression cells for 
determination of optimal expression conditions.  
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6. Figures 
  
PDB: 1HLU, 2BTU 
Figure 1. X-ray crystal structure of an actin monomer. This structure shows an actin monomer 
in its open (green) and closed (blue) states. The 4 subdomains are labeled by number and the 
nucleotide binding cleft is bound with ATP (red). The hydrophobic cleft binds to G-actin binding 
proteins, including profilin.  
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Figure 2. Time course of ACD activity. Significant crosslinking of actin monomers occurs within 
the first 15 minutes of combining active ACD with actin at room temperature. Formation of 
many higher order structures is observed within this time frame.  
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PDB: 4EAH 
Figure 3. X-ray crystal structure of FH2 dimer from FMNL3 in complex with actin monomers. 
Purple and blue each represent one FH2 domain within the dimer. The lasso region at the N-
terminus is able to interact with the post at the C-terminus of the next subunit to stabilize the 
dimer. The homodimer forms a donut structure which is able to surround an actin filament and 
remain attached. 
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Figure 4. A) Accepted mechanism of formin-mediated actin polymerization in the presence of 
profilin. The poly-proline regions farthest from the filament have the strongest binding affinity 
for profilin-actin complexes while regions closer have weaker affinity and allow for quicker 
incorporation of these complexes into the filament. B) Our proposed mechanism for how 
profilin-bound actin oligomers block mDia1 mediated polymerization in the presence of profilin. 
C) An alternative proposed mechanism where actin oligomers are able to bind across FH1 arms, 
rather than along the tandem sites of a single FH1 arm.  
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Figure 5.  Time course of ACD activity in the presence of human profilin. Profilin concentration 
is 1.2x excess of actin concentration (10 uM), being crosslinked by 20 nM of ACD. 
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Figure 6. mDia1 purification SDS-PAGE. Lysate is shown after application and washing in the 
column. Washes represent increasing concentrations of imidazole for elution. Eluted 
contaminants cannot be visualized in 10 mM imidazole washes because they are significantly 
diluted in this step (50 mL total volume in each lane).  
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Figure 7. Yields of mDia1 before (left panel) and after (right panel) addition of free 0.5 M poly-L-
proline. Panels show the first six elution fractions of protein in 250 mM imidazole.  
 
Figure 8. Comparison of storage methods for 2 week old mDia. 3 methods were used to 
attempt to preserve the protein: storage in 50% glycerol, storage in 50% ethylene glycol, and 
storage on ice. After 2 weeks, most significant activity loss was seen in mDia1 stored on ice. 
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Ethylene glycol stock activity was preserved much better than on ice, but not as well as the 
glycerol which was ultimately chosen as our storage method.  
 
Figure 9. Example of ACD contamination being present in bulk-pyrene polymerization assays. 
Oligomers were added to the experiment in the nanomolar range, which should not be 
visualized by SDS-PAGE because the concentration is too low. Seeing actin oligomers by SDS-
PAGE implies that additional monomeric actin was being crosslinked during the polymerization 
assay, meaning active ACD was still present. This can be affirmed by the slightly depleted 
monomeric actin bands at the bottom of the gel. All actin bands should be equal in size, but 
samples with large amounts of oligomers present also exhibit a depletion of the monomeric 
actin pool.  
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Figure 10. Control experiments to show the effects of actin oligomers on actin polymerization 
in the absence of profilin. Conditions used: 2.5 uM pyrene actin, 5 uM profilin, 5 nM mDia1. The 
green line represents the polymerization rate of actin alone, in the presence of 1 mM MgCl2. 
Addition of actin oligomers does not significantly affect the polymerization rate. Blue 
represents the rate of mDia1 accelerated polymerization, and addition of actin oligomers 
(purple) also does not significantly inhibit this reaction. O=Oligomers.  
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Figure 11. Observation of the effect of actin oligomers on mDia1 mediated polymerization in 
the presence of profilin. Conditions used: 2.5 uM pyrene actin, 5 uM profilin, 5 nM mDia1. 
Profilin is shown to function properly as it sequesters actin monomers and slows polymerization 
on its own (red line). mDia1 in the presence of profilin shows the greatest rate of 
polymerization (blue line), and is then inhibited in a stepwise fashion as increasing 
concentrations of actin oligomers (purple lines) are titrated into the system. M=mDia1, 
P=hProfilin, O=Oligomers with their concentration at that specific point added in parentheses.  
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Figure 12. Isothermal binding curve calculated using sub-stochiometric concentrations of actin 
oligomers, relative to the concentration of mDia1. The calculated affinity value from this curve 
is 0.089 nM, suggesting a very strong interaction between profilin bound actin oligomers and 
the FH1 domain. This curve gives an apparent KD because we study a mixed population of actin 
oligomers as opposed to a homogenous population. 
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Figure 13. SDS-PAGE showing heterodimer expression at 37 C, compared to mDia1 expression. 
First two lanes for heterodimer show total and supernatant of unexpressed cells versus the 
next two lanes which show total and supernatant after expression. Bands corresponding in size 
to FH1FH2 and FH2 are shown on the gel by arrows.  
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